Loading organizations...
NaoX Technologies is a technology company.
NaoX Technologies develops in-ear electroencephalography (EEG) solutions. Its NAOX LINK, an FDA-authorized intra-auricular device, provides medical-grade, long-duration brain activity tracking for neurology, epilepsy, sleep, and research. They also offer NAOX WAVE, an EEG platform for consumer earables, capturing brain biomarkers for cognitive states.
Founded in 2018, NaoX Technologies resulted from Hugo Dinh and Michel Le Van Quyen's collaboration. Dinh, a medical device-focused École Polytechnique alumnus, partnered with Le Van Quyen, a renowned neuroscience expert. Their insight: democratize EEG, moving it beyond clinical settings for enhanced neurological disorder management.
NaoX Technologies targets healthcare and consumer electronics. Its vision makes electroencephalograms widely accessible, translating high-quality brain activity insights from labs into daily life. This strategy improves diagnosis and monitoring, fostering proactive brain health management via integrated technology.
NaoX Technologies has raised $5.0M across 1 funding round.
NaoX Technologies has raised $5.0M in total across 1 funding round.
NaoX Technologies has raised $5.0M in total across 1 funding round.
NaoX Technologies's investors include Kurma Partners, BNP Paribas Développement, So-Yeon KOO, Majycc eSant.
NaoX Technologies is a Paris-based neurotechnology company founded in 2018 that develops NAOX Buds, connected earphones with miniature EEG sensors for brain activity monitoring.[1][2][3] These devices target the healthcare sector, enabling detection and monitoring of neurological disorders through simplified, everyday-wear EEG recordings that overcome traditional sensors' complexity and clinical limitations.[1][2] Serving researchers, healthcare providers, and defense partners, NaoX addresses the problem of inaccessible brain monitoring by integrating EEG into wireless headphones for robust, on-the-go use.[2][3] The company has raised $4.79M (€4.3M in its latest 2022 seed round from investors like Kurma Partners and Bpifrance) and remains in seed VC stage with one patent filed for brain electric potential measurement.[1]
NaoX Technologies emerged in 2018 in Paris, France, driven by the need to make EEG sensors simpler and more accessible beyond clinical settings.[1][2][5] While specific founders are not detailed in available sources, the company quickly gained traction through its innovative approach: embedding EEG technology into everyday headphones to track brain function robustly.[2] A pivotal moment came in January 2022 with a €4.3M funding round led by Kurma Partners, Bpifrance's Patient Autonomy Fund, BNP Paribas Développement, and Majycc e-Santé, validating its potential in research, health, and defense applications.[1] Headquartered at 96 bis boulevard Raspail (with some records noting 130 Rue De Lourmel), NaoX has maintained steady growth as an active seed-stage firm with under 25 employees and revenue below $5M.[3]
NaoX rides the neurotechnology wave in health tech, where wearable EEG innovations address rising demands for remote neurological monitoring amid aging populations and post-pandemic telehealth shifts.[1][2][6] Timing aligns with market forces favoring miniaturized, non-invasive sensors—traditional EEG's limitations (complexity, immobility) create opportunities for ambulatory solutions like NAOX Buds, influencing diagnostics for epilepsy, sleep disorders, and brain health.[1][5] By enabling everyday brain data collection, NaoX contributes to the MedTech ecosystem, partnering across research, health, and defense to democratize access and accelerate treatments for neurological diseases.[2][6]
NaoX Technologies stands poised for expansion in wearable neurotech, potentially advancing to clinical trials, regulatory approvals (e.g., FDA/CE marking), and partnerships with pharma or device giants for scaled adoption.[1][2] Trends like AI-driven EEG analysis and consumer brain-health wearables will shape its path, amplifying impact on decentralized diagnostics. Its influence may evolve from seed innovator to ecosystem leader, enhancing global neurological care as funding and patent maturation unlock broader commercialization—echoing its core mission to simplify brain monitoring from the start.[1][5]
NaoX Technologies has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $5.0M Seed | Kurma Partners, BNP Paribas Développement, So-Yeon KOO, Majycc eSant |